BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 8:11:26 AM | Browse: 1173 | Download: 2604
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 59413
Country China
Received
2020-10-22 14:08
Peer-Review Started
2020-10-22 14:08
First Decision by Editorial Office Director
2021-01-07 19:40
Return for Revision
2021-01-07 19:40
Revised
2021-01-16 13:14
Publication Fee Transferred
Editorial Processing by Scientific Editor
2021-02-22 03:32
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2021-03-08 06:08
Articles in Press
2021-03-08 06:08
Edit the Manuscript by Language Editor
2021-03-14 02:03
Typeset the Manuscript
2021-03-29 12:20
Publish the Manuscript Online
2021-04-09 08:11
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Case Report
Article Title Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
Manuscript Source Unsolicited Manuscript
All Author List Lin Xiao, Lie Sun, Kang Zhao and Yi-Sheng Pan
ORCID
Author(s) ORCID Number
Lin Xiao http://orcid.org/0000-0001-8644-1568
Lie Sun http://orcid.org/0000-0001-5609-530X
Kang Zhao http://orcid.org/0000-0001-5253-6139
Yi-Sheng Pan http://orcid.org/0000-0001-7256-5017
Funding Agency and Grant Number
Corresponding Author Yi-Sheng Pan, MD, Doctor, Doctor, Department of General Surgery, Peking University First Hospital, No. 8 Xishiku Street, Beijing 100034, China. bdyypanyisheng@163.com
Key Words Crohn's disease; Infliximab; Colon cancer; Rectum cancer; Inflammatory bowel disease; Tumor necrosis factor; Case report
Core Tip Crohn's disease can result in diffuse intestinal lesions, including intestinal edema, stenosis, and even mucosal bleeding, which makes pathological diagnosis difficult. Although tumor necrosis factor-alpha inhibitors are efficacious for inflammatory bowel disease, they may contribute to malignancy in particularly susceptible individuals. This case demonstrates that when a patient is receiving long-term treatment with infliximab, it is important to monitor for the development of neoplasia. When neoplasia is found, surgical resection must be performed in time to prevent tumor progression and spread.
Publish Date 2021-04-09 08:11
Citation Xiao L, Sun L, Zhao K, Pan YS. Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report. World J Gastrointest Oncol 2021; 13(4): 305-311
URL https://www.wjgnet.com/1948-5204/full/v13/i4/305.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i4.305
Full Article (PDF) WJGO-13-305.pdf
Full Article (Word) WJGO-13-305.docx